SEQUA — Sequana Medical NV Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Annual income statement for Sequana Medical NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.37 | 0.923 | 0.712 | 0.105 | 0.712 |
| Cost of Revenue | |||||
| Gross Profit | -2.42 | -2.44 | -4.18 | -3.24 | — |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 23 | 29 | 29.6 | 18.3 | — |
| Operating Profit | -22.6 | -28.1 | -28.9 | -18.2 | — |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -23.2 | -30.4 | -32.1 | -44.4 | — |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -23.6 | -30.8 | -32.6 | -44.7 | — |
| Net Income Before Extraordinary Items | |||||
| Net Income | -23.6 | -30.8 | -32.6 | -44.7 | — |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -23.6 | -30.8 | -32.6 | -44.7 | — |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.3 | -1.35 | -1.22 | -1.22 | — |